574 filings
Page 7 of 29
6-K
MOR
Morphosys AG
22 Nov 23
Current report (foreign)
10:41am
6-K
MOR
Morphosys AG
21 Nov 23
Topline Results Phase 3 MANIFEST-2 Study Pelabresib in First-Line Myelofibrosis November 2023 Gail, Living with Myelofibrosis since 2018
10:08am
6-K
MOR
Morphosys AG
20 Nov 23
Current report (foreign)
4:55pm
6-K
MOR
Morphosys AG
20 Nov 23
Current report (foreign)
10:06am
6-K
MOR
Morphosys AG
16 Nov 23
Current report (foreign)
10:22am
F-3ASR
MOR
Morphosys AG
16 Nov 23
Automatic shelf registration (foreign)
9:27am
6-K
MOR
Morphosys AG
16 Nov 23
Half-Year Report JANUARY – JUNE
9:25am
6-K
MOR
Morphosys AG
16 Nov 23
MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results
9:03am
6-K
MOR
Morphosys AG
16 Nov 23
Third Quarter Interim Statement JANUARY – SEPTEMBER 2023
6:00am
6-K
MOR
Morphosys AG
14 Nov 23
Current report (foreign)
10:28am
6-K
MOR
Morphosys AG
13 Nov 23
Current report (foreign)
10:07am
6-K
MOR
Morphosys AG
13 Nov 23
Current report (foreign)
6:25am
6-K
MOR
Morphosys AG
9 Nov 23
Current report (foreign)
10:32am
6-K
MOR
Morphosys AG
7 Nov 23
Current report (foreign)
10:05am
6-K
MOR
Morphosys AG
2 Nov 23
MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting
9:20am
6-K
MOR
Morphosys AG
27 Oct 23
Current report (foreign)
10:26am
S-8 POS
MOR
Morphosys AG
26 Oct 23
Registration of securities for employees (post-effective amendment)
12:41pm
6-K
MOR
Morphosys AG
26 Oct 23
Current report (foreign)
10:06am
6-K
MOR
Morphosys AG
25 Oct 23
Current report (foreign)
11:28am
6-K
MOR
Morphosys AG
25 Oct 23
Current report (foreign)
10:30am